Jove
Visualize
Contact Us

Related Experiment Videos

Using bioinformatics and genome analysis for new therapeutic interventions.

David W Mount1, Ritu Pandey

  • 1Arizona Cancer Center, University of Arizona, 1515 North Campbell Avenue, P.O. Box 245024, Tucson, AZ 85724-5024, USA. mount@u.arizona.edu

Molecular Cancer Therapeutics
|October 18, 2005
PubMed
Summary

The genome era offers insights into gene variations and protein functions for novel cancer therapy discovery. Cancer bioinformatics analyzes this data to identify drug targets and enable personalized cancer treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sphingosine kinase 1 is dysregulated via hypoxia-inducible factor 1α in oral squamous cell carcinoma.

The Indian journal of medical research·2026
Same author

Challenging conventional wisdom: A fresh look at the litter effect in rats.

The Journal of physiology·2026
Same author

A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma.

Cancers·2025
Same author

miRNA genetic variations associated with the predisposition of oral squamous cell carcinoma in central Indian population.

Non-coding RNA research·2024
Same author

Gene Expression Patterns Associated with Survival in Glioblastoma.

International journal of molecular sciences·2024
Same author

Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers.

Molecular therapy. Oncology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • The genome era provides vast data on human genes, proteins, and their variations.
  • Understanding genetic variations is crucial for identifying cancer predispositions and disease mechanisms.
  • Genome-wide analysis of cancer cells is key to discovering new therapeutic targets.

Purpose of the Study:

  • To leverage genome resources for the discovery of new cancer therapies.
  • To organize and analyze diverse genomic and proteomic data for trend identification.
  • To facilitate the development of targeted therapeutic interventions and personalized medicine.

Main Methods:

  • Utilizing information on human genes, encoded proteins, and population-level genetic variation.
  • Performing genome-wide analysis of cancer cells and tissues.

Related Experiment Videos

  • Employing cancer bioinformatics for data organization and pattern identification.

    • Main Results:

    • Identification of specific gene and protein targets critical for cancer cell survival.
    • Development and evaluation of therapeutic agents directed against identified targets.
    • Establishing molecular and genetic variation as a basis for individualized cancer treatment.

    Conclusions:

    • Genome-wide data analysis is essential for advancing cancer therapy discovery.
    • Cancer bioinformatics plays a critical role in translating genomic information into clinical applications.
    • Personalized medicine approaches, guided by individual genetic profiles, hold significant promise for cancer treatment.